Navigation Links
Founder of National Children's Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
Date:5/9/2012

LONDON, May 9, 2012 /PRNewswire/ -- A monumental discovery that provides the promise of a cure not only for leukaemia, but cancer at large was announced this morning in London during GIL 2012: Europe. Steve Shor, the founder of the National Children's Leukemia Foundation, a leading non-profit organisation in the United States, unveiled a ground-breaking therapy his research teams in the United States and Israel have discovered. Mr. Shor and National Program Director, Dr. Sara Gardin, presented this new non-embryonic stem cell treatment for cancer and leukaemia, referred to as the "Stem cell cocktail" which delivers a combination of therapies including core stem cells and various compounds to tackle cell metastasization.

Just a few weeks ago, this unique approach to tackling one of the most prominent forms of cancer of our time received initial patent approval with full patents expected in the coming months.

Steve Shor delivered an emotional appeal and address that captured the undivided attention of some two hundred plus senior level business executives representing this global network of visionaries, innovators and leaders gathered in London for Frost & Sullivan's GIL 2012: Europe - Journey to Visionary Innovation. Mr. Shor, a construction business owner from Brooklyn, New York, who had given up his successful career in 1992 to search out a bone marrow donor, when he discovered that his 17-year old son had been diagnosed with leukaemia. His son unfortunately never received a bone marrow transplant and lost his fight with leukaemia. Steve has continued to dedicate his life to cancer research founding the National Children's Leukemia Foundation and working with scientists in hopes to find "The Cure."

"I always thought the cure for cancer had to come from core stem cells," Steve said. "We started from a very different point. We asked: what are the mechanisms that make cancer cells grow?"

First time trial left them sceptical bu
'/>"/>

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Radiotherapy Clinics of Georgias Founder Returns Home to Celebrate Cancer Survivors and Receive Lifetime Achievement Award
2. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
3. Pandora Founder Tim Westergren and Co-Discoverer of DNA Dr. James Watson Meet
4. Founder of Cryonics Movement Dies, is Frozen at Cryonics Institute
5. Generex Announces U.S. Congressman Curt Weldon, Co-Founder of the Congressional Diabetes Caucus, to Champion Generex Initiatives in Asia and North America
6. Most Expensive Teas in the World Worth US$44,500 per 4 Ounces Each are Positioned for International Distribution Says Protein Reactor Combined Fuels Inc (OTC: PRCF) Founder Chairman and CEO Nestor C. Buenaflor
7. Glencoe Software and Open Microscopy Environment Founder Awarded the BBSRC Innovator of the Year 2011
8. HumanTouch Founder, President and CEO, Moe Jafari Named Washington Business Journal Minority Business Leader Honoree
9. Cord Blood America CEO and Co-Founder Matthew Schissler Named Chairman of Biotech Committee for Nevada Development Authority
10. Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D.
11. Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... and NEW YORK , ... PTBI, PTBIW), a biopharmaceutical company advancing patient care in ... offering of 3,500,000 shares of common stock, and warrants ... common stock, at an offering price of $4.00 per ... per share exercise price of $5.00, are exercisable immediately, ...
(Date:12/24/2014)... Earlier this year in a June 24 international ... Adult Stem Cell Technology Center, LLC ( ASCTC ) ... unique property of adult tissue stem cells. His ... the Past, Important for the Future,” embodied the essence ... the address at the 4th World Congress on Cell ...
(Date:12/24/2014)... Nashville Fertility Center announced that Dr. George ... Society for Reproductive Medicine (ASRM), a leading professional organization ... In his new role as treasurer, Dr. Hill ... will have a voice in furthering the mission of ... since 1984 when he joined while conducting fellowship training ...
(Date:12/24/2014)... PharmaBoardroom,s new report, , Healthcare and ... free download , digs deep into this vibrant market, ... sector today. One area where Algeria ... a homegrown pharmaceutical manufacturing base, even if the government,s ambitious ... off. A cursory comparison with neighboring Morocco ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3
... Inc. launched Tinidazole 500, the first generic version of ... oral antimicrobial drug approved by the FDA for the ... BioComp Pharma will begin shipping the generic version ... active ingredients and efficacy as branded drugs but, on ...
... Key Secondary Endpoints -- CAPACITY 1 Misses Primary Endpoint, ... and MAA -BRISBANE, Calif., Feb. 3 InterMune, Inc. ... the two Phase 3 CAPACITY studies evaluating pirfenidone in ... endpoint of change in percent predicted Forced Vital Capacity ...
... feat for any company. Last year, Alkemists Labs reaped the benefit ... at the right time" and showed year over year sales growth of ... ... Sudberg, Founder, CEO and Chief Scientific Officer of Alkemists Labs proudly announces ...
Cached Biology Technology:BioComp Pharma Launches First Generic Drug for Tindamax(R) 2BioComp Pharma Launches First Generic Drug for Tindamax(R) 3InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 2InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 3InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 4InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 5InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 6InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 7InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 8InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 9InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 10InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 11Alkemists Labs Wins Nutrition Business Journal's 2008 Industry Growth Award 2Alkemists Labs Wins Nutrition Business Journal's 2008 Industry Growth Award 3
(Date:12/22/2014)... 22, 2014 Research and Markets ... addition of the "The Global Watermarking ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... overview of the global digital media watermarking ... and monitor piracy by securely and invisibly ...
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced ... America Perimeter Security Systems Market" report to their ... The North American perimeter security market is estimated ... to 2019. Although the U.S. market holds a larger ... is expected to grow at a higher CAGR of ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint ... http://photos.prnewswire.com/prnh/20130307/600769 ... than the iPhone 5S, Samsung introduces for the ... The Galaxy S5 home button presents ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... ranging from medical devices such as MRIs to surveillance balloons ... 1996, Congress directed the government to sell essentially all of ... for its investment in the helium and its storage. ... the National Research Council, assesses whether selling off the reserve ...
... performance on a video game simply by measuring the volume ... this week. The new study, in the journal ... variability in achievement seen among men and women trained on ... volume of three structures in their brains. The study ...
... the exploration of the human mind in the hope ... origin of thought to the nature of knowledge. Today ... emerging fields of research in various areas, an approach ... project from Wiley-Blackwell. The content of this journal will ...
Cached Biology News:Video gamers: Size of brain structures predicts success 2Video gamers: Size of brain structures predicts success 3
... years of expertise in the field of ... the most powerful systems on the market. ... 000 in-microplate tests requiring incubation and washing ... modules (such as worktable shaker incubators, reader,washer), ...
... pre-validated SNP sequencing services ... within 93 genes including ... more than 80 tyrosine ... were developed and validated ...
... Mouse anti-Yersinia pestis F1 antigen, ... Applications: ELISA: Use at ... at an assay dependent dilution. WB: ... Predicted molecular weight: 18 kDa. Not ...
... Fixation medium Reagent B - Permeabilisation medium ... cells in suspension with Reagent A and ... This procedure gives antibodies access to intracellular ... of the cells intact. Specific formulations reduce ...
Biology Products: